OBJECTIVE: To characterize the audiometric phenotype of autosomal-dominant DFNA34 hearing loss (HL) caused by a missense substitution in the NLRP3 gene. NLRP3 encodes a critical component of the NLRP3 inflammasome that is activated in innate immune responses. STUDY DESIGN: This study was conducted under protocol 01-DC-0229 approved by the NIH Combined Neurosciences IRB. We performed medical and developmental history interviews and physical and audiological examinations of affected individuals with DFNA34 HL caused by the p.Arg918Gln mutation of NLRP3. We retrospectively reviewed audiological reports, when available, from other health care centers. SETTING: Federal biomedical research facility. SUBJECTS: Eleven members of a North American family segregating p.Arg918Gln. MAIN OUTCOME MEASURES: Pure-tone thresholds, rates of pure-tone threshold progression, and speech discrimination scores. RESULTS: Eight subjects had bilateral sensorineural HL with an onset in the late 2nd to 4th decade of life. Slowly progressive HL initially primarily affected high frequencies. Low and middle frequencies were affected with advancing age, resulting in moderate HL with a downsloping audiometric configuration. The average annual threshold deterioration was 0.9 to 1.5 dB/yr. Speech recognition scores ranging from 60 to 100% were consistent with cochlear, but not retrocochlear, etiology. Three subjects (16, 22, and 32 yr old) had normal hearing thresholds. CONCLUSION: DFNA34 HL has an onset during early adulthood and progresses approximately 1.2 dB/yr.
OBJECTIVE: To characterize the audiometric phenotype of autosomal-dominant DFNA34 hearing loss (HL) caused by a missense substitution in the NLRP3 gene. NLRP3 encodes a critical component of the NLRP3 inflammasome that is activated in innate immune responses. STUDY DESIGN: This study was conducted under protocol 01-DC-0229 approved by the NIH Combined Neurosciences IRB. We performed medical and developmental history interviews and physical and audiological examinations of affected individuals with DFNA34HL caused by the p.Arg918Gln mutation of NLRP3. We retrospectively reviewed audiological reports, when available, from other health care centers. SETTING: Federal biomedical research facility. SUBJECTS: Eleven members of a North American family segregating p.Arg918Gln. MAIN OUTCOME MEASURES: Pure-tone thresholds, rates of pure-tone threshold progression, and speech discrimination scores. RESULTS: Eight subjects had bilateral sensorineural HL with an onset in the late 2nd to 4th decade of life. Slowly progressive HL initially primarily affected high frequencies. Low and middle frequencies were affected with advancing age, resulting in moderate HL with a downsloping audiometric configuration. The average annual threshold deterioration was 0.9 to 1.5 dB/yr. Speech recognition scores ranging from 60 to 100% were consistent with cochlear, but not retrocochlear, etiology. Three subjects (16, 22, and 32 yr old) had normal hearing thresholds. CONCLUSION:DFNA34HL has an onset during early adulthood and progresses approximately 1.2 dB/yr.
Authors: N J D Weegerink; M Schraders; J Leijendeckers; K Slieker; P L M Huygen; L Hoefsloot; J Oostrik; R J E Pennings; A Simon; A Snik; H Kremer; H P M Kunst Journal: Hear Res Date: 2011-07-23 Impact factor: 3.208
Authors: Hiroshi Nakanishi; Yoshiyuki Kawashima; Kiyoto Kurima; Jae Jin Chae; Astin M Ross; Gineth Pinto-Patarroyo; Seema K Patel; Julie A Muskett; Jessica S Ratay; Parna Chattaraj; Yong Hwan Park; Sriharsha Grevich; Carmen C Brewer; Michael Hoa; H Jeffrey Kim; John A Butman; Lori Broderick; Hal M Hoffman; Ivona Aksentijevich; Daniel L Kastner; Raphaela Goldbach-Mansky; Andrew J Griffith Journal: Proc Natl Acad Sci U S A Date: 2017-08-28 Impact factor: 11.205
Authors: O Vahava; R Morell; E D Lynch; S Weiss; M E Kagan; N Ahituv; J E Morrow; M K Lee; A B Skvorak; C C Morton; A Blumenfeld; M Frydman; T B Friedman; M C King; K B Avraham Journal: Science Date: 1998-03-20 Impact factor: 47.728
Authors: Michael S Hildebrand; Adam P DeLuca; Kyle R Taylor; David P Hoskinson; In Ae Hur; Dylan Tack; Sarah J McMordie; Patrick L M Huygen; Thomas L Casavant; Richard J H Smith Journal: Laryngoscope Date: 2009-11 Impact factor: 3.325
Authors: N G Robertson; L Lu; S Heller; S N Merchant; R D Eavey; M McKenna; J B Nadol; R T Miyamoto; F H Linthicum; J F Lubianca Neto; A J Hudspeth; C E Seidman; C C Morton; J G Seidman Journal: Nat Genet Date: 1998-11 Impact factor: 38.330
Authors: L Van Laer; E H Huizing; M Verstreken; D van Zuijlen; J G Wauters; P J Bossuyt; P Van de Heyning; W T McGuirt; R J Smith; P J Willems; P K Legan; G P Richardson; G Van Camp Journal: Nat Genet Date: 1998-10 Impact factor: 38.330
Authors: Hal M Hoffman; Sanna Rosengren; David L Boyle; Jae Y Cho; Jyothi Nayar; James L Mueller; Justin P Anderson; Alan A Wanderer; Gary S Firestein Journal: Lancet Date: 2004 Nov 13-19 Impact factor: 79.321
Authors: Raphaela Goldbach-Mansky; Natalie J Dailey; Scott W Canna; Ana Gelabert; Janet Jones; Benjamin I Rubin; H Jeffrey Kim; Carmen Brewer; Christopher Zalewski; Edythe Wiggs; Suvimol Hill; Maria L Turner; Barbara I Karp; Ivona Aksentijevich; Frank Pucino; Scott R Penzak; Margje H Haverkamp; Leonard Stein; Barbara S Adams; Terry L Moore; Robert C Fuhlbrigge; Bracha Shaham; James N Jarvis; Kathleen O'Neil; Richard K Vehe; Laurie O Beitz; Gregory Gardner; William P Hannan; Robert W Warren; William Horn; Joe L Cole; Scott M Paul; Philip N Hawkins; Tuyet Hang Pham; Christopher Snyder; Robert A Wesley; Steven C Hoffmann; Steven M Holland; John A Butman; Daniel L Kastner Journal: N Engl J Med Date: 2006-08-10 Impact factor: 91.245
Authors: Parveen Bazard; Jennifer Pineros; Robert D Frisina; Mark A Bauer; Alejandro A Acosta; Lauren R Paganella; Dominika Borakiewicz; Mark Thivierge; Freyda L Mannering; Xiaoxia Zhu; Bo Ding Journal: Cells Date: 2021-10-15 Impact factor: 6.600
Authors: Emily A Caseley; Samuel Lara-Reyna; James A Poulter; Joanne Topping; Clive Carter; Fatima Nadat; Gavin P Spickett; Sinisa Savic; Michael F McDermott Journal: J Clin Immunol Date: 2021-10-21 Impact factor: 8.317
Authors: Dominika Oziębło; Marcin L Leja; Aldona Jeznach; Magdalena Orzechowska; Tomasz Skirecki; Ewa Więsik-Szewczyk; Mariusz Furmanek; Natalia Bałdyga; Henryk Skarżyński; Monika Ołdak Journal: Front Immunol Date: 2022-05-26 Impact factor: 8.786